Clinical

BioWorld biopharma clinical, regulatory and conference charts include worldwide news of phase I, phase II and phase III clinical development by biopharmaceutical companies developing therapeutics, as well as all actions by global regulatory authorities and clinical data reported at industry conferences. Collected from BioWorld.

Deals

BioWorld biopharma deals charts include all global for-profit licensings, collaborations, joint ventures and various other agreements in which at least one party is a biopharmaceutical company developing therapeutics. Nonprofit deals between biopharma companies and government entities or nonprofit institutions are separated into their own category. Collected from BioWorld and Cortellis.

BioWorld medical technology deals charts include all global for-profit licensings, collaborations, joint ventures and various other agreements in which at least one party is a medical device, diagnostic or other company involved in developing technologies for medical use. Collected from BioWorld and Cortellis.

BioWorld Asia deals charts include all for-profit licensings, collaborations, joint ventures and various other agreements in which at least one party is based in Asia and a biopharmaceutical company developing therapeutics. Collected from BioWorld and Cortellis.

Financings

BioWorld biopharma financings charts include all global public and private financings, including IPOs (listings on Canadian, U.S. and European, Australian, Hong Kong and China exchanges), follow-ons, private placements and venture capital rounds, as well as loans, of biopharmaceutical companies developing therapeutics. They do not include grants or money received through deals. Collected from BioWorld.

BioWorld biopharma grants charts include all grants received by biopharmaceutical companies developing therapeutics from government and nonprofit entities. Collected from BioWorld and Cortellis.

BioWorld medical technology financings charts includes all global public and private financings, including IPOs, follow-ons, private placements and venture capital rounds, as well as loans, of medical device, diagnostic and other companies developing technologies for medical use. They do not include grants or money received through deals. Collected from BioWorld.

BioWorld Asia biopharma financings charts include all public and private financings, including IPOs, follow-ons, private placements and venture capital rounds, as well as loans, of biopharmaceutical companies, based in Asia, that are developing therapeutics. They do not include grants or money received through deals. Collected from BioWorld.

Indexes

The BioWorld biopharma stock index includes more than 500 U.S. stocks of biopharmaceutical companies developing therapeutics.

The BioWorld medical technology stock index includes about 230 U.S. stocks of medical device, diagnostic and other companies developing technologies for medical use.

The BioWorld Asia biopharma stock index includes 20 stocks of Asian biopharmaceutical companies developing therapeutics.

M&As

BioWorld biopharma M&A charts include all completed global mergers and acquisitions in which at least one party is a biopharmaceutical company developing therapeutics. Collected from BioWorld and Cortellis.

BioWorld medical technology M&A charts include all completed global mergers and acquisitions in which at least one party is a medical device, diagnostic or other company involved in developing technologies for medical use. Collected from BioWorld and Cortellis.

U.S. FDA Approvals

BioWorld's coverage of drugs approved by the U.S. FDA includes supplementals for new indications but does not include over-the-counter medicines, new doses or generic approvals for already counted drugs. See here for the FDA's glossary of terms.